IDH1 and oligodendroglioma: We compared this watch-and-wait approach to the standard early postoperative adjuvant oncological treatment using case matching for both grade 3 oligodendrogliomas, IDH-mutant and 1p/19q-codeleted and astrocytomas, IDH-mutant.